Cannara Biotech's market cap is currently $76.52M. The company's EPS TTM is C$0.071; its P/E ratio is 11.89; Cannara Biotech is scheduled to report earnings on January 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Income Statement
Total Revenue	C$ 81.75M	C$ 57.26M	C$ 35.84M	C$ 17.02M	C$ 2.55M
Gross Profit	C$ 29.79M	C$ 27.23M	C$ 17.33M	C$ 10.30M	C$ 1.22M
Operating Income	C$ 10.08M	C$ 11.89M	C$ 3.67M	C$ 192.60K	C$ -11.93M
EBITDA	C$ 15.16M	C$ 15.77M	C$ 9.54M	C$ 3.22M	C$ -9.15M
Net Income	C$ 6.44M	C$ 6.95M	C$ 2.31M	C$ -3.09M	C$ -13.81M
Balance Sheet
Cash & Short-Term Investments	C$ 6.62M	C$ 4.27M	C$ 12.11M	C$ 8.16M	C$ 7.77M
Total Assets	C$ 154.72M	C$ 141.52M	C$ 125.62M	C$ 92.02M	C$ 54.85M
Total Debt	C$ 48.33M	C$ 45.78M	C$ 48.39M	C$ 20.90M	C$ 12.94M
Net Debt	C$ 41.71M	C$ 41.51M	C$ 36.28M	C$ 12.74M	C$ 5.16M
Total Liabilities	C$ 66.77M	C$ 61.78M	C$ 58.88M	C$ 27.91M	C$ 16.49M
Stockholders' Equity	C$ 87.95M	C$ 79.74M	C$ 66.74M	C$ 64.12M	C$ 38.36M
Cash Flow
Free Cash Flow	C$ 3.21M	C$ -4.44M	C$ -21.55M	C$ -33.17M	C$ -18.14M
Operating Cash Flow	C$ 10.68M	C$ 5.44M	C$ -6.08M	C$ -2.09M	C$ -9.32M
Investing Cash Flow	C$ -5.19M	C$ -9.48M	C$ -15.35M	C$ -30.83M	C$ -8.55M
Financing Cash Flow	C$ -3.14M	C$ -3.72M	C$ 25.46M	C$ 33.25M	C$ -914.82K

Currency in CAD

Cannara Biotech Earnings and Revenue History

Income Statement >

Cannara Biotech Debt to Assets

Balance Sheet >

Cannara Biotech Cash Flow

Cash Flow >

Cannara Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing